Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)
Crossref DOI link: https://doi.org/10.1007/s10096-016-2865-8
Published Online: 2017-01-22
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mendes, R. E.
Sader, H. S.
Smart, J. I.
Castanheira, M.
Flamm, R. K.
Funding for this research was provided by:
Theravance Biopharma Antibiotics, Inc.
License valid from 2017-01-22